Kevin Roarty Lab

  1. Baylor College of Medicine
  2. Research
  3. Faculty Labs
  4. Kevin Roarty Lab
  5. Publications

Roarty Publications

Master
Heading

Peer-Reviewed Publications

Content

Selected Publications:

  1. Roarty K. Taking shape: Intercalation within the mammary terminal end bud. Dev Cell. 2023 Jul 10;58(13):1123-1125. doi: 10.1016/j.devcel.2023.05.001. PubMed PMID: 37433279.
  2. Si H, Esquivel M, Mendoza Mendoza E, Roarty K. The covert symphony: cellular and molecular accomplices in breast cancer metastasis. Front Cell Dev Biol. 2023;11:1221784. doi: 10.3389/fcell.2023.1221784. eCollection 2023. Review. PubMed PMID: 37440925; PubMed Central PMCID: PMC10333702.
  3. Roarty K. Unlocking the secrets of cancer stem cells: Immune checkpoint inhibitors face their formidable foes. Cell Stem Cell. 2023 Jun 1;30(6):743-744. doi: 10.1016/j.stem.2023.05.011. PubMed PMID: 37267909.
  4. Si H, Zhao N, Pedroza A, Zaske AM, Rosen JM, Creighton CJ, Roarty K. Noncanonical Wnt/Ror2 signaling regulates cell-matrix adhesion to prompt directional tumor cell invasion in breast cancer. Mol Biol Cell. 2022 Sep 15;33(11):ar103. doi: 10.1091/mbc.E22-02-0055. Epub 2022 Aug 24. PubMed PMID: 36001375; PubMed Central PMCID: PMC9582800.
  5. Zhao N, Powell RT, Yuan X, Bae G, Roarty KP, Stossi F, Strempfl M, Toneff MJ, Johnson HL, Mani SA, Jones P, Stephan CC, Rosen JM. Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition. Nat Commun. 2021 Jul 12;12(1):4262. doi: 10.1038/s41467-021-24545-3. PubMed PMID: 34253738; PubMed Central PMCID: PMC8275587.
  6. Roarty K, Echeverria GV. Laboratory Models for Investigating Breast Cancer Therapy Resistance and Metastasis. Front Oncol. 2021;11:645698. doi: 10.3389/fonc.2021.645698. eCollection 2021. Review. PubMed PMID: 33777805; PubMed Central PMCID: PMC7988094.

Full Publication link HERE: https://www.ncbi.nlm.nih.gov/myncbi/kevin.roarty.1/bibliography/public/